Elite Pharmaceuticals, Inc. (ELTP) earnings
ELTP earnings moved a median of -5.79% by the close. Quarterly and annual ELTP reports and results, each read against the price at its own news timestamp. Back to the ELTP overview →
14 measured ELTP earnings events.
Where these ELTP earnings landedvs 14 measured ELTP earnings reactions
| Middle 50% of ELTP earnings reactions | -10.96% to +2.08% |
|---|---|
| Median reaction (to close) | -5.79% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 ELTP earnings events with a measured close landed between -10.96% and +2.08%; 29% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -3.50% | +3.33% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | +1.22% | -7.62% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | -9.15% | -16.91% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.70% | -8.38% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.57% | -11.04% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | -3.32% | -13.97% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | +1.09% | +17.75% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -1.89% | +12.32% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -1.31% | -3.97% | |
| Form 10-K ELITE PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-K | -0.02% | -10.74% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-Q | -3.56% | -11.06% | |
| Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024 | Press release | -4.86% | -2.40% | |
| Form 10-Q ELITE PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +14.02% | +11.11% | |
| Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023 | Press release | — | -1.67% |
Keep exploring
More ELTP: analyst actions → · SEC filings → · ELTP overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Homology Medicines, Inc. (FIXX) | 80 | -0.34% | 33% |
| Orchard Therapeutics plc - American Depositary Shares (ORTX) | 80 | +0.06% | 66% |
| Genetic Technologies Ltd - American Depositary Shares (GENE) | 79 | -0.05% | 33% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.